In conclusions, advanced Ann Arbor Stage, higher number of extranodal site, high serum LDH level, high IPI score, high ECOG score, bone marrow involvement, high VEGF, high IL-8, high IL-10, and positive RIP2 were all risk factors of DLBCL overall survival time. This evidence concerns the gene VEGFA and diffuse large B-cell lymphoma.